(corresponding to 2 pg of reverse-transcribed RNA) was used to quantitatively target the housekeeping gene B2M. The three assays were highly linear over the examined range (see the online Data Supplement). Likewise, in a 10-fold dilution series of a FLJ10350 cDNA clone ranging from 10 9 to 10 copies per reaction, assayed by all three assays, real-time quantification was linear, although it showed more deviation among the triplicates performed on low amounts of template (see the online Data Supplement).
We analyzed expression of three genes that had been found, by SYBR Green I analyses, to be differentially expressed in patients with congenital heart defects (17 ). The results confirmed the previously published data, with FLJ10350 and TNNI1 being significantly up-regulated and PIPPIN being significantly down-regulated (see the online Data Supplement). Throughout our assays, we saw no amplification of the no-template controls (see the online Data Supplement).
For normalization of the target genes analyzed in the course of this study, the housekeeping gene B2M was simultaneously assayed with the genes of interest. The obvious sample-to-sample variations (see the online Data Supplement) stress the importance of effective systems for normalization, as achieved with the multiplexed cr-realtime PCR assay.
In summary, we have described a single-step method for real-time PCR that is sensitive, robust, and requires minimal optimization effort. Because the system uses nonmodified, tailed amplification primers and universal reporting reagents, it is characterized by a flexible and low-cost format. The use of differentially labeled reporting reagents enables multiplexing approaches for monitoring of more than one target per well, e.g., both a candidate and housekeeping gene. Therefore, the cr-realtime PCR assay appears suitable for the broad spectrum of real-time PCR applications. This work was funded by EU FP6 Grant 503155 (Moltools). We are grateful to Martin Lange for providing the FLJ10350 cDNA clone and Bogac Kaynak for providing the cDNA samples. We thank Maike Tribbels and Christina Grimm for critical reading of the manuscript. (6 ) . ACE2 was first identified as a homolog of angiotensinconverting enzyme with zinc metalloproteinase activity (7 ). Many of its activities differ from those of angiotensinconverting enzyme (8 ) . ACE2 has been found to be an important regulator of cardiac function (9 ) . Since the identification of ACE2 as the functional receptor for the SARS coronavirus (6 ), efforts have been spent on characterizing its molecular interaction with the virus (10, 11 ) . On the other hand, studies on mouse hepatitis virus, a group 2 coronavirus (12 ), demonstrated that allelic variants of viral receptor were associated with altered virusbinding activity, which mediated host susceptibility (13 ) . Hence, it is plausible that genetic variants of ACE2 may moderate the effects of SARS coronavirus infection and, possibly, gender-specific effects.
For this study, we obtained institutional ethics approval. We identified 103 single-nucleotide polymorphisms (SNPs) in ACE2, using the University of Washington and Fred-Hutchinson Cancer Research Center Variant Discovery Resource, SeattleSNPs (14 ) . Two of the identified SNPs were located within the coding regions [dbSNP identification nos. rs4646116 and rs4646179 (15 )], whereas the remainder were located within the introns of ACE2. SNP validation by direct sequencing of the 101 noncoding SNPs was conducted with use of buffy coat DNA obtained from 10 female Chinese volunteers. This validation strategy allows the detection of SNPs with minor allele frequencies of at least 10% at 90% power. The two coding SNP loci were verified on buffy coat DNA from 20 female Chinese. Forty-eight pairs of primers were designed to facilitate direct sequencing of ACE2 regions spanning all of the SNPs. Buffy coat DNA was extracted according to the Blood and Body Fluid Spin protocol in manufacturer's instructions for the QIAamp DNA Blood Mini Kit (Qiagen). DNA sequencing was performed by the dideoxy dye terminator method on an automated DNA sequencer (3100 Genetic Analyzer; Applied Biosystems) based on capillary electrophoresis. Sequences were edited and aligned, and comparisons were made with the SeqScape software (Applied Biosystems).
SNP validation confirmed sequence variations at five sites ( Table 1 ). All five SNP loci were noncoding. Both of the coding SNPs were shown to be nonpolymorphic among the 20 females. The positions and orientations of the five verified SNPs are illustrated in Fig. 1 . A casecontrol study was conducted to compare the frequencies of the five polymorphisms among 168 SARS patients (81 males and 87 females, among whom 30 males and 16 females had poor outcomes) from the Prince of Wales Hospital, Hong Kong (4 ), and 328 healthy volunteers (174 males and 154 females). All of the individuals studied were unrelated individuals of Chinese ethnicity. Genotype characterization was performed with TaqMan (Applied Biosystems) allelic discrimination assays on an ABI Prism 7900HT sequence detection system (Applied Biosystems). Each assay consisted of two allele-specific minor groove binding probes with different fluorescent labels, i.e., 6-carboxyfluorescein (FAM) or VIC TM , designed for the discrimination of the two respective alleles at each SNP locus. The assays were set up according to the manufacturer's instructions (TaqMan Core PCR Kit; Applied Biosystems) in a reaction volume of 10 L. The primers and fluorescent probes were used at concentrations of 900 and 200 nM, respectively. We used 10 ng of buffy coat DNA for amplification. The thermal profile consisted of an initial denaturation period for 10 min at 95°C, followed by 40 cycles of denaturation at 92°C for 15 s, and 1 min of combined annealing and extension at either 62°C (SNPs rs2285666, rs4646142, and rs714205) or 65.5°C (SNPs rs2106809 and rs2074192; Table 1 ). The genotypes were scored with the SDS2.1 software.
The allele frequencies for the SARS and control groups are listed in Table 1 . When we used the allele frequencies obtained from the control group, the group sample size provided a power of at least 80% for the determination of a genetic factor that contributes 50% increased likelihood toward the development of SARS or poor outcome with 95% confidence. Statistical significance among groups was examined by the 2 test for each SNP locus (SigmaStat, Ver. 3.0; SPSS). Statistical significance was denoted by a two-tailed P Ͻ0.05. No significant difference was observed in the allele distributions between the female and male controls (data not shown), between the SARS cases and controls, between SARS cases with poor outcomes and controls, between the male SARS patients with poor outcome and the male controls, or between the female SARS patients and female controls ( Table 1 ). The observed genotype distributions for each of the five loci among the female controls did not deviate significantly from those expected from the Hardy-Weinberg equilibrium. The genotype frequencies for each of the five SNP loci were not statistically significantly different between the female SARS patients and the female controls. Because males are hemizygous for ACE2, the genotype frequency is equivalent to the allele frequency.
We therefore conclude that although ACE2 serves functionally as the receptor for entry of the SARS coronavirus into human host cells, the evidence provided by this study does not support an association between its common genetic variants and SARS susceptibility or outcome. Despite its X-chromosome location, poor outcomes in male SARS patients do not appear to be related to genetic variants of ACE2.
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